Gastric carcinoma: Expression of c-erbB-2/neu oncoprotein, epidermal growth factor receptor, cathepsin D, progesterone receptor and tumor associated glycoprotein-72 in different histological types

Revista Espanola de Enfermedades Digestivas

Volumn 91, Issue 12, 1999, Pages 832-837

  Del Carmen Pelaez Bujan, Ma ^a,d   Ruibal Morell, A ^b   Aza Gonzalez J ^c  

^a HOSPITAL EL BIERZO   (Spain)

^b Ctro Patol la Mama (Dr Tejerina)   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d NONE   (Mexico)

Author keywords

catD; EGFR; Neu; PR; Stomach neoplasm; TAG 72

Indexed keywords

CATHEPSIN D; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLYCOPROTEIN; PROGESTERONE RECEPTOR;

ADENOCARCINOMA; AGED; ARTICLE; BIOSYNTHESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STOMACH TUMOR;

ADENOCARCINOMA; AGED; CATHEPSIN D; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; MALE; PROSPECTIVE STUDIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTORS, PROGESTERONE; STOMACH NEOPLASMS;

EID: 0039929539     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
2. Okada M, Kojima S, Murakami L. Human gastric carcinoma: prognosis in relation to macroscopic and microscopic features of the primary tumor. J Natl Cancer Inst 1983;71: 275-9.
3. Sjöstedt S, Pieper K. Gastric cancer. Factors influencing long term survival and postoperative mortality. Acta Chir Scand 1986;530:25-9.
4. Tahara E, Semba S, Tahara H. Molecular biological observations in gastric cancer. Sem Oncol 1996;23:307-15.
5. Vollmers HP, Dämmrich J, Hensel F, Ribbert H, Meyer-Bahlburg A. Differential expression of apoptosis receptors on diffuse and intestinal type stomach carcinoma. Cancer 1997;79:433-40.
6. Wu MS, Shun CT, Wang HP, Shen JC, Lee WJ, Wang TH, et al. Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage and Helicobacter pylori infection. Gastroenterology 1997;112:1457-65.
7. Lupu R, Colomer R, Zugmaier G. Direct interaction of a ligand for the c-erbB-2 oncogene product with the EGF receptor and p185/erB-2. Science 1990;249:1552-5.
8. Abe S, Sasano H, Katoh K, Ohara S, Arikawa T, Noguchi T, et al. Immunohistochemical studies on EGF family growth factors in normal and ulcerated human gastric mucosa. Dig Dis Sci 1997;42:1199-209.
9. Koullias GJ, Kouraklis GP, Raftopoulos IS, Davaris PS, Papadopoulos SA, Golematis BC. Increased estrogen receptor and epidermal growth factor receptor gene product co-expression in surgically resected gastric adenocarcinomas. J Surg Oncol 1996;63:166-71.
10. Theodoropoulos GE, Lazaris AC, Panossopoulos D, Davaris P, Golematis BC. Significance of estrogen receptors and cathepsin D tissue detection in gastric adenocarcinoma. J Surg Oncol 1995;58:176-83.
11. Allgayer H, Babic R, Grutzner KU, Beyer BC, Tarabichi A, Willhelm Schildberg F, et al. An immunohistochemical asessment of cathepsin D in gastric carcinoma: its impact on clinical prognosis. Cancer 1997;80:179-87.
12. Westley B, Rochefort H. Estradiol induced proteins in the MCF-7 human breast cancer cell line. Biophys Res Commun 1979;4:410-6.
13. Stemmermann GN, Brown CA. A survival study of intestinal and diffuse types of gastric carcinoma. Cancer 1994;33: 1190-5.
14. Nardulli AM, Greene GL, O'Malley BW, Katzenellenbogen BS. Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: Analysis of estrogen's effect on progesterone receptor synthesis and degradation. Endocrinology 1988;122:935-44.
15. Wu CW, Chi CW, Chang TJ, Lui WY, P'eng FK. Sex hormone receptors in gastric cancer. Cancer 1990;65:1396-400.
16. Jacobs E, Watson SA, Hardcastle JD, Robertson JF. Oestrogen and progesterone receptors in gastrointestinal cancer cell lines. Eur J Cancer 1996;32:2348-53.
17. Singh S, Poulsom R, Wright NA, Sheppard MC, Langman MJ. Differential expression of oestrogen receptor and oestrogen inducible genes in gastric mucosa and cancer. Gut 1997;40:516-20.
18. Colcher D, Minelli MF, Roselli M, Muraro R, Simpson-Milenic D, Schlom J. Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies. Cancer Res 1988;48:4597-603.
19. Thor A, Ohuchi N, Szpack CA, Johnston WW, Schlom J. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res 1986;46:3118-24.
20. Sagredo E, Soriano A, Pombo L, Roiz MC, Allende MT, Ruibal A. CA 72.4 serum levels in 298 patients with non-malignant diseases. Int J Biol Markers 1995;10:100-6.
21. Guadagni F, Roselli M, Cosimelli M, Ferroni P, Spila A, Casaldi V, et al. Correlation between positive CA 72-4 serum levels and lymph node involvement in patients with gastric carcinoma. Anticancer Res 1993;13:2409-13.
22. Webb A, Scott-Mackie P, Cunnigham D. The prognosis value of serum and immunohistochemical tumor markers in advanced gastric cancer. Eur J Cancer 1996;32:63-8.
23. Joypaul B, Browning M, Newman E, Byrne D, Cuschieri A. Comparison of serum CA 72-4 and CA 19-9 levels in gastric cancer patients and correlation with recurrence. Am J Surg 1995;169:595-9.
24. Martín-Pérez E, Fernández-Arjona M, Baza B, Villanueva C, Larrañaga E, Serrano PA, et al. Determinación del marcador tumoral CA 72-4 en el carcinoma gástrico. Rev Esp Enferm Dig 1993;83:92-6.
25. Adachi Y, Mori M, Maehara Y, Sugimachi K. Duke's classification: a valid prognostic indicator for gastric cancer. Gut 1994;35:1371-86.
26. Nakamura K, Sugano H, Takagi K. Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gann 1968;59:251-8.
27. Ming S. Gastric carcinoma: a pathobiological classification. Cancer 1977;39:2475-85.
28. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988;48:3554-60.
29. Ramón JM, Serra L, Cerdó C, Oromí J. Dietary factors and gastric cancer risk. A case-control study in Spain. Cancer 1993;71:1731-5.
30. Correa P. Helicobacter pylori and gastric cancer: state of the art. Cancer Epidemiol Biomarkers Prev 1996;5:477-81.
31. Stemmermann G, Heffelfinger SC, Noffsinger A, Zhong Y, Miller MA, Fenoglio-Preiser CM. The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumor supressor genes and growth factors. Human Pathol 1994;25:968-81.
32. Lee WJ, Lih JT, Shun CT. Comparison between resectable gastric adenocarcinomas seropositive and seronegative for Helicobacter pylori. Br J Surg 1995;82:802-5.
33. Solzia E, Fiocca R, Luinetti O. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg Pathol 1996;20:S8-S22.
34. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 1986;8:1-27.
35. Maehara Y, Moriguchi S, Kajeki Y. Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis. Surgery 1991;110:820-3.
36. Mori M, Sakaguchi H, Akazara K, Tsuneypshi M, Sueishi K, Sugimachi K. Correlation between metastatic site, histological type and serum tumor markers of gastric carcinoma. Hum Pathol 1995;26:504-8.
37. Namieno T, Koito K, Higashi T, Sato N, Uchino J. General pattern of lymph node metastases in early gastric carcinoma. World J Surg 1996;20:996-1000.
38. Moriguchi S, Maehara Y, Korenaga D, Sugimachi K, Nose Y. Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer. Surg Oncol 1992;1:341-6.
39. Falck VG, Gollick W. c-erbB-2 oncogene product staining in gastric adenocarcinoma: an immunohistochemical study. J Pathol 1989;159:107-11.
40. Kameda T, Yasui W, Yoshida K. Expression of erbB2 in human gastric carcinomas: relationship between p185erbB2 expression and the gene amplification. Cancer Res 1990; 50:8002-9.
41. Mizutani T, Onda M, Tokunaga A, Yamanaka N, Sugisaki N. Relationship of c-erbB-2 protein expression and gene amplificaton to invasion and metastasis in human gastric cancer. Cancer 1993;72:2083-8.
42. Amadori D, Maltoni M, Volpi A, Nanni O, Scarpi E, Renault B, et al. Gene amplification and proliferative kinetics in relation to prognosis of patients with gastric carcinoma. Cancer 1997;79:226-32.
43. McCulloch PG, Ochiai A, O'Dowd GO, Nash JR, Sasako M, Hirohashi S. Comparison of the molecular genetics of c-erbB-2 and p52 expression in stomach cancer in Britain and Japan. Cancer 1995;75:920-5.
44. Jahne J, Urmarcher C, Albino A, Meyer HJ, Pichlmayr R. Molecular biologische und immunohistochemische untersuchungen zum Her2/neu-onkogen beim magencarcinom. Chirurg 1994;65:307-11.
45. Albino AP, Jaehne J, Altorki N. Amplification of HER-2/neu gene in human gastric adenocarcinomas: correlation with primary site. Eur J Surg Oncol 1995;21:56-60.
46. Yonemura Y, Ninomiya I, Ohoyama S. Expression of c-erbB-2 oncoprotein in gastric carcinoma. Cancer 1991;67: 2914-8.
47. Kim YJ, Gun HD, Kim DY, Kim HJ, Kim SK, Parks CS. Expression of cellular oncogenes in human gastric carcinoma: c-myc, c-erbB2 and c-Ha-ras. J Surg Oncol 1993;54: 167-70.
48. Sano T, Tsujino T, Yoshida K. Frequent loss of heterozigosity on chromosomes 1q, 5q and 17p in human gastric carcinomas. Cancer Res 1991;51:2926-31.
49. Motojima K, Furui J, Kohara N, Izawa K, Kanematsu T, Shiku H. erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection. Surgery 1994;115:349-54.
50. Lin JT, Wu MS, Shun CT, Lee WJ, Shen JC, Wang TH. Occurrence of microsatellite instability in gastric carcinoma is associated with enhanced expression of erbB-2 oncoprotein. Cancer Res 1995;55:1428-30.
51. Tannapfel A, Kuhn R, Kessler H, Witekind C. Expression of c-erbB-2 oncogene product in different tumors and its standarised evaluation. Ann Cell Pathol 1996;10:149-60.
52. García M, Derocq D, Pujol P, Rochefort H. Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene 1990;5:1809-14.
53. Rochefort H, Liaudet E, García M. Alterations and role of human cathepsin D in cancer metastasis. Enzyme Protein 1996;49:106-16.
54. Montcourier P. Maugeat PH, Salazr G, Morisset M, Sahuquet A, Rochefort H. Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. Cancer Res 1990;50:6045-54.
55. Tokunaga A, Nishi K, Matsukura N. Estrogen and progesterone receptors in gastric cancer. Cancer 1986;57:1376-9.
56. Ruibal Morell A. Nuevos factores pronósticos. Membrana celular. En: Ruibal Morell A (ed). El cáncer de mama: biología y marcadores tumorales. Madrid: Ene Ediciones; 1996. p. 68-9.